Search

everythinglearnresearchcommunity

for

Search:↓

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Dupilumab can both cause and treat alopecia areata, with many patients experiencing hair regrowth.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

A woman with IgG/IgA pemphigus was treated successfully with dapsone and steroids.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

A woman with skin eruptions and hair loss improved significantly with ointment treatment.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Dermoscopy helped diagnose a rare skin disease which slightly improved with treatment.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

Biopsy is crucial to correctly diagnose granuloma annulare, which can mimic other conditions like alopecia mucinosa.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Korean psoriasis patients still use alternative medicine despite effective biologics.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Enhancing Tregs can protect against alopecia areata.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.